| Antibodies - Deciphering the Chemistry Behind Antibody Tetramerization |
|
|
|
|
| |
|
| |
The latest antibodies news from News Medical |
|
|
|
 | | |
 Targeting Checkpoint Proteins on NK Cells: Enhancing Immunotherapy Strategies
NK cells have been shown to independently eliminate cancers, making them a promising target for immunotherapies. They are a promising therapeutic focus, especially against chemotherapy-resistant cancers. Maintaining the equilibrium between inhibitory and activating signals is pivotal for NK cell function. ACROBiosystems offers NK cell immune checkpoint proteins to aid drug and therapy development.
| |
|
|
|
|
|
 | | |  Antibodies (immunoglobulins) are Y-shaped proteins that recognize and neutralize specific pathogens. Their ability to target specific molecules or cells has made them promising candidates for future drug development. | | | | |  Research reveals that T cell migration relies on ion and water influx for actin polymerization and movement, with the WNK1 kinase playing a critical role in regulating these processes, offering new insights into adaptive immunity. | | | | |  Researchers conducting a Phase 2 clinical trial at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine say a new combination of antibody therapies produced a 'surprisingly high' response rate in patients with high-risk follicular lymphoma, a type of non-Hodgkin lymphoma. | |
|
|
|
| | How would you rate today's newsletter?
| |
|
|
|
|
|
.png)
